Rare diseases
Investigational molecules
Locations
Back to Czechia8 clinical trials in Havlickuv Brod, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
CzechiaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
CzechiaStudy on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis
CzechiaStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
CzechiaStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
CzechiaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
CzechiaStudy on the Effects of Itepekimab in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on atherosclerotic cardiovascular disease treatment evaluation, specifically testing new therapeutic approaches for patients whose current lipid-modifying therapies need enhancement.
Studies include assessment of major cardiovascular events and coronary interventions.
Comprehensive research into Chronic Obstructive Pulmonary Disease, evaluating new treatment combinations and therapeutic approaches for moderate to severe cases.
Multiple trials focusing on reducing exacerbation rates and improving patient outcomes.
Advanced research examining novel combination therapies for heart failure, with particular focus on treatments for patients with specific ejection fraction parameters.
Trials aim to improve outcomes in heart failure management through innovative therapeutic combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
